William Heiden

William Heiden currently serves as Chairman of the Board at MacroGenics, Inc., Third Pole Therapeutics, and CoreA Therapeutics, as well as a Board Trustee at Boston Collegiate Charter School. Additionally, William holds a position on the Board of Directors at Atara Biotherapeutics, Inc. Experience includes roles as President, CEO, and Director at AMAG Pharmaceuticals, along with board memberships at PhRMA, Genzyme Transgenics Corporation, and LFB. William's educational background includes an MBA in Management from Cornell Johnson Graduate School of Management, a Master's in International Management from Universite Catholique de Louvain, and a BS in Finance from the University of Florida.